PSMA PET/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness | Synapse
March 7, 2026Open Access
PSMA PET/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness
Key Points
The research aims to evaluate the accuracy and cost-effectiveness of PSMA PET/CT in diagnosing and staging high grade prostate cancer.
Assessment of PSMA PET/CT imaging accuracy
Analysis of cost-effectiveness compared to traditional methods
Evaluation of therapy initiation timing based on imaging results
High accuracy demonstrated in diagnosing high grade prostate cancer
Cost-effectiveness improved with the use of PSMA PET/CT
Facilitated faster initiation of therapy after diagnosis
Abstract
PSMA PET/CT as a single imaging procedure demonstrated an high accuracy in diagnosing and staging high grade PCa, moreover, improved cost-effectiveness and allowed to start quickly therapy.